Literature DB >> 18211537

Follicular fluid levels of interleukin-10 and interferon-gamma do not predict outcome of assisted reproductive technologies.

Zivile Cerkiene1, Audrone Eidukaite, Audrone Usoniene.   

Abstract

PROBLEM: Follicular fluid (FF) and surrounding tissue contains various lymphocytes that synthesize different cytokines. The other sources of cytokines are ovarian somatic cells. FF provides microenvironment for the oocyte and contains immunological factors for the regulation of its development. Changes in expression and concentrations of certain cytokines can influence oocyte and embryo quality, resulting in a reduced ability to implant. Some data shows that follicular environment depends on infertility indication. The purpose of our study was to investigate whether cytokines interleukin-10 (IL-10) and interferon-gamma (IFN-gamma) are released in the human FF and also to evaluate impact of those cytokines on fertilization rate, cleavage rate, embryo quality, and pregnancy rate. METHODS OF STUDY: Couples treated by assisted reproductive technologies were selected for this study. A total of 121 patients participated in the study. Until cytokine detection samples of FF were stored at -20 degrees C. In vitro fertilization or intracytoplasmic sperm injection procedure was used depending on the indication. After 72 hr, on the day of transfer, embryo morphology was evaluated. Embryo transfer based on embryo morphology was performed. Commercial enzyme-linked immunosorbent assay kit from Diaclone, France was used for the quantitative determination of human IL-10 and IFN-gamma concentrations in FF. Analysis of the results was performed using spss 12.0.
RESULTS: One hundred and twenty-one FF samples were tested for IL-10 and IFN-gamma. IFN-gamma and IL-10 were detected in 14 (11.6%) and 108 (89.3%) FF samples, respectively (range 0.9-31.1 pg/mL for IFN-gamma and 0.7-10.8 pg/mL for IL-10). There was no significant correlation between infertility indication, fertilization rate, cleavage rate, and concentrations of the follicular cytokines. Similarly, IL-10 concentrations did not differ significantly in different age groups and did not alter pregnancy rate.
CONCLUSION: Our study showed that IFN-gamma and IL-10 are not suitable markers in predicting outcome of assisted reproductive technologies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18211537     DOI: 10.1111/j.1600-0897.2007.00552.x

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  5 in total

1.  Effects of sera taken from women with recurrent spontaneous abortion on sperm motility and apoptosis.

Authors:  Tahereh Talaei-Khozani; Zahra Borzoei; Soghra Bahmanpour; Jaleh Zolghadr; Sedigheh Dehbashi; Hamid Reza Zareh
Journal:  Iran J Reprod Med       Date:  2011

Review 2.  Follicular fluid content and oocyte quality: from single biochemical markers to metabolomics.

Authors:  Alberto Revelli; Luisa Delle Piane; Simona Casano; Emanuela Molinari; Marco Massobrio; Paolo Rinaudo
Journal:  Reprod Biol Endocrinol       Date:  2009-05-04       Impact factor: 5.211

3.  CD80 and CD86 costimulatory molecules differentially regulate OT-II CD4⁺ T lymphocyte proliferation and cytokine response in cocultures with antigen-presenting cells derived from pregnant and pseudopregnant mice.

Authors:  Tomasz Maj; Anna Slawek; Anna Chelmonska-Soyta
Journal:  Mediators Inflamm       Date:  2014-03-19       Impact factor: 4.711

4.  Comparative multiplex analysis of cytokines, chemokines and growth factors in follicular fluid of normoresponder women undergoing ovum donation with gonadotropin-releasing hormone agonist versus gonadotropin-releasing hormone antagonist protocols.

Authors:  Neena Malhotra; Akhilesh Srivastava; Harpal Rana; Anupama Bahadur; Jayasree Sengupta; Debabrata Ghosh
Journal:  J Hum Reprod Sci       Date:  2013-07

Review 5.  Metabolite Profiling in the Pursuit of Biomarkers for IVF Outcome: The Case for Metabolomics Studies.

Authors:  C McRae; V Sharma; J Fisher
Journal:  Int J Reprod Med       Date:  2013-01-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.